Abstract
The effect of a single injection of L-triiodothyronine (T3) on the levels of liver cholesterol and liver 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) has been studied in chicken. A minimal dose of 8 micrograms/animal produces its maximal effects after 12 h. T3 enhances both HMGR activity and cholesterol levels in liver. Both effects are suppressed when protein synthesis inhibitors (actinomycin D or cycloheximide) are administered along with the hormone. Solubilized and membrane-bound HMGR activities are equally influenced by the hormone. The in vitro addition of T3 does not affect the HMGR activity. It is concluded that T3 increases cholesterol biosynthesis in chicken liver through the activation of de novo protein synthesis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
